Deguelin , 10mMinDMSO , 522-17-8

Synonym(s):
(7aS,13aS)-13,13a-Dihydro-9,10-dimethoxy-3,3-dimethyl-3H-bis[1]benzopyrano[3,4-b:6′,5′-e]pyran-7(7aH)-one

CAS NO.：522-17-8

Empirical Formula: C23H22O6

Molecular Weight: 394.42

MDL number: MFCD01740600

EINECS: 200-258-5

PRODUCT Properties

• Melting point: 85-87 °C(lit.)
• alpha: D27 -97.2° (c = 0.2 in benzene)
• Boiling point: 560.1±50.0 °C(Predicted)
• Density: 1?+-.0.06 g/cm3(Predicted)
• storage temp.: -20°C
• solubility: DMSO: >10 mg/mL
• form: solid
• color: white to yellow
• optical activity: [α]/D -70 to -80°, c = 0.2 in methanol
• Stability: Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.

Description and Uses

Rotenoids, deriving from the flavonoid family of compounds, act as chemopreventive agents that inhibit NADH:ubiquinone oxidoreductase activity and suppress phorbol ester-induced ornithine decarboxylase (ODC) activity. The rotenoid compound deguelin, originally isolated from the bark of M. sericea (Leguminosae) to be used as an insecticide and fish poison, has chemopreventive and chemosensitizing effects in models of skin, mammary, colon, and lung carcinogenesis. Deguelin inhibits cell growth (IC₅₀ = <10-8 M), blocks PI3K/Akt activation, suppresses COX-2 expression, and induces apoptosis in premalignant and squamous human bronchial epithelial (HBE) cells without affecting normal HBE cells. At 6 mg/kg, deguelin induces Parkinson’s disease-like symptoms in rats after six days of subcutaneous infusion and therefore may also serve as a useful model for Parkinson’s disease research.

antineoplastic, antiviral, insecticide, ornithine decarboxylate inhibitor

Safety

• Symbol(GHS): GHS07
• Signal word: Warning
• Hazard statements: H315-H319-H335
• Precautionary statements: P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501
• Safety Statements: 22-24/25
• WGK Germany: 3
• RTECS: DX1500000
• HS Code: 29329990